Blood Thinner Recalled

Macleods Pharma is recalling a single lot of clopidogrel tablets, citing the “presence of a foreign matter,” according to the September 8, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 500-count bottles of clopidogrel tablets, 75 mg (NDC 33342-060-15), from lot BCA82021A (Exp. 6/23). The tablets were manufactured by Macleods Pharmaceutical Ltd, Himachal Pradesh, India, and distributed by Macleods Pharma USA, Plainsboro, NJ, throughout the United States.

Macleods Pharma voluntarily initiated the recall August 2, 2021. On August 31, 2021, the FDA designated the recall Class II, which warns use of the drug may cause temporary or medically reversible adverse health consequences or a remote possibility of serious harm.

Clopidogrel is a prescription blood thinner used to prevent heart attack, stroke, and other heart problems.